Skip to main content
Signal8

Exter Neil

SEC insider (Form 3/4/5 filer). CIK 0001620014. Director at Maze Therapeutics, Inc. (MAZE). 2 reported Form 4/5 transactions since Sep 2024; latest on Sep 22, 2025. Located in SOUTH SAN FRANCISCO, CA.

Companies Exter Neil has filed insider reports for

  • Maze Therapeutics, Inc. (MAZE): Director
Exter Neil profile photo

Exter Neil

CIK: 0001620014

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Maze Therapeutics, Inc. logo
MAZE

Maze Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Maze Therapeutics, Inc. logo
    MAZE

    Maze Therapeutics, Inc.

    Sep 22, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    18K shares-
  • Maze Therapeutics, Inc. logo
    MAZE

    Maze Therapeutics, Inc.

    Aug 17, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    16K shares-

1-2 of 2